JANX vs SPG · rev $10.3M vs rev $3.55B
Janux Therapeutics Inc (JANX) versus SPG (SPG) — a side-by-side from cached financials, not a winner call.
Janux Therapeutics Inc (JANX) is a biotechnology company listed on US.
SPG (SPG) common stock.
Latest reported JANX revenue for 2026-06-30 was $10.3M. Net income was -$22.0M. JANX currently screens at market cap $1.49B.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
JANX currently screens at market cap $1.49B. SPG currently screens at market cap $0.
Not investment advice. Open the JANX and SPG stock pages for the full models.
Not investment advice.